-
1
Impact of EML4‐ALK Variants and TP53 Status on the Efficacy of ALK Inhibitors in Patients With Non‐small Cell Lung Cancer
Published 2025-01-01Subjects: “…EML4‐ALK…”
Get full text
Article -
2
EML4‐ALK‐Positive Ovarian Cancer With Intracranial Metastasis Responds to Lorlatinib: A Case Report and Literature Review
Published 2025-01-01Subjects: “…EML4‐ALK fusion gene…”
Get full text
Article